In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1719 News Items found
SKI immunologist Justin Perry holding a fish
Meet Justin Perry, a “Card-Carrying Alaskan” Whose Love for Science Took Him on an Unexpected Journey

Read an interview with Sloan Kettering Institute immunologist Justin Perry.
Stacia Smart and Owen Strong
Owen and Stacia: A Love Story

Discover how cyclist Stacia Smart turned her grief into purpose after her boyfriend died of a brain tumor.
Sam Frackowiak, part of the Radiochemistry and Molecular Imaging Probe Core Facility, operates a robotic arm to prepare a radioactive theranostic drug that will seek out and destroy cancer cells.
Theranostics: A Smart Bomb for Cancer

When Dave Norkin was diagnosed at 39 with a rare cancer, he was told he had just months to live. Now, a decade later, he’s surviving — thanks to the emerging field of theranostics, which combines imaging and therapy for a search-and-destroy mission.
Craig B. Thompson, President and Chief Executive Officer of Memorial Sloan Kettering
To Our MSK Community

A generous gift provides a major boost to translational research at MSK.
Photo of a man, woman, and child sitting outside smiling
Translating Science Into Cures: Bringing Fresh Hope to the Denisiuk Family

Mark Denisiuk was diagnosed with acute myeloid leukemia in the spring of 2021. He found hope when he enrolled in an early trial of an entirely new kind of drug that’s based on lab research conducted at MSK.
Memorial Sloan Kettering patient Rebecca Lerner smiling in the hospital
Unlocking a Mystery: What’s Behind the Rise In Colorectal Cancer Among Young People

Doctors and scientists at MSK are desperately trying to figure out why more young patients like Rebecca, 33, are getting colorectal cancer — and how best to treat them.
A Fred’s Team runner giving a high five
Your Impact: Celebrating Our Donors’ Support in 2021

Learn about how our donor community is funding life-changing cancer research at Memorial Sloan Kettering and ensuring a brighter future for people with cancer around the world.
Dana Pe'er
“Beautiful Patterns in Biology”: How SKI’s Dana Pe’er Earned a Top Honor and Advocates for Women Scientists

Read an interview with Sloan Kettering Institute Computational and Systems Biology Chair Dana Pe'er.
Physician-scientist Nai-Kong Cheung
Caging the Beast: MSK Researchers Design a New Radiation Treatment More Destructive to Cancer Cells

Learn about the work of Nai-Kong Cheung and other MSK scientists who have learned more about how to deliver stronger treatment with less toxicity.
Human metastatic melanoma cells in a lymph node. ENPP1, a protein involved in immune evasion, is shown in green.
Taking the STING Out of Cancer: Discovery about How Cancer Cells Evade Immune Defenses Inspires New Treatment Approach

The research identifies a protein called ENPP1 as a potential drug target in the treatment of advanced cancers with chromosome instability.